Tenaculum Pain Control Study

Phase 4

Completed

Interventions: Drug: Topical Lidocaine Gel
Drug: Intracervical Lidocaine Injection

Brief Summary: The purpose of this clinical trial is to evaluate the effect of an intracervical lidocaine injection versus topical lidocaine gel on the pain experienced by patients undergoing tenaculum application to the cervix during office gynecologic procedures. This study will also evaluate how satisfied women are with the method of pain control used.

The researchers hypothesize that:

1. There is less pain perceived by patients undergoing placement of a tenaculum on the cervix when a lidocaine injection is used compared to a topical lidocaine gel.

2. Patients are more satisfied with pain control during the overall experience of undergoing tenaculum placement on the cervix when a lidocaine injection is used compared to a topical lidocaine gel.

Detailed Description: Subjects who have already scheduled an IUD insertion or endometrial biopsy will be asked to join this study assessing two pain control interventions at the time of tenaculum application to the cervix during office gynecologic procedures. Only healthy women ages 18 and over with an indication for endometrial biopsy or IUD placement will be recruited. The participants will be randomized to one of two arms: an intracervical lidocaine injection versus topical lidocaine gel. They will be asked to indicate their level of pain and level of satisfaction using a Visual Analog Scale. The primary outcome, pain with tenaculum placement, and the secondary outcome, satisfaction with the experience of tenaculum placement, will be compared between the study groups.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

Allergy to lidocaine or other local anesthetic
Pregnancy, known or suspected
Patients who are premedicated with misoprostol
Patients with a chronic pain condition for which the patient takes daily pain medication

Arm && Interventions

Group	Intervention	Description
Topical Lidocaine Gel	Topical Lidocaine Gel	Application of 1cc of 2% lidocaine gel to the anterior lip of the cervix with a Q-tip (this amount of lidocaine will be measured out prior to procedure)
Intracervical Lidocaine Injection	Intracervical Lidocaine Injection	Injection of 2 cc of 1% lidocaine solution at the anterior lip of the cervix using a standard 22 gauge spinal needle.

Primary Outcome Measures

Name	Time	Method
Tenaculum Pain	After tenaculum placement	The primary outcome was pain at the time of tenaculum placement. Patient asked to pain scale using 100mm Visual Analog Scale (0mm=no pain, 100mm=worst pain of my life) during after tenaculum placement.

Secondary Outcome Measures

Name	Time	Method
Tenaculum Placement Satisfaction	After placement of the tenaculum	Satisfaction with overall tenaculum placement procedure. Subjects asked to answer their overall satisfaction with the pain control. Subjects asked to complete 100mm Visual Analog Scale (0mm=not at all satisfied to 100mm=very satisfied)
Intervention Pain	after application of randomized intervention	Pain with the intervention (injection or gel application). Subjects are asked to complete pain scale using a 100mm Visual Analog Scale (0mm=no pain and 100mm=worst pain of my life)